Dynamic enhancement of drug product labels to support drug safety, efficacy, and effectiveness

Journal of Biomedical Semantics

Volumn 4, Issue 1, 2013, Pages

  Boyce, Richard D ^a   Horn, John R ^b   Hassanzadeh, Oktie ^c   Waard, Anita de ^d   Schneider, Jodi ^e   Luciano, Joanne S ^f   Rastegar Mojarad, Majid ^g   Liakata, Maria ^h,i  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c IBM T J WATSON RESEARCH CENTER   (United States)

^d ELSEVIER MASSON   (France)

^e NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^f RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^g UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^h ABERYSTWYTH UNIVERSITY   (United Kingdom)

ⁱ EUROPEAN BIOINFORMATICS INSTITUTE   (United Kingdom)

Author keywords

Comparative effectiveness research; Drug information services; Drug interactions; Drug labeling; Linked data; Pharmacokinetics; Regulatory science; Scientific discourse ontologies; Treatment effectiveness; Treatment efficacy

Indexed keywords

EID: 84931093028     PISSN: None     EISSN: 20411480     Source Type: Journal    
DOI: 10.1186/2041-1480-4-5     Document Type: Article

References (50)

1. Marroum PJ, Gobburu J: The product label: how pharmacokinetics and pharmacodynamics reach the prescriber. Clin Pharmacokinetics 2002,41(3):161-169. [ http://www.ncbi.nlm.nih.gov/pubmed/11929317 ]. [PMID: 11929317]
2. Ko Y, Malone D, Skrepnek G, Armstrong E, Murphy J, Abarca J, Rehfeld R, Reel S, Woosley R: Prescribers' knowledge of and sources of information for potential drug-drug interactions: a postal survey of US prescribers. Drug Safety: An Int J Med Toxicol Drug Experience 2008,31(6):525-536. [ http://www.ncbi.nlm.nih.gov/pubmed/18484786 ]. [PMID: 18484786]
3. FDA: CFR - Code of Federal Regulations Title 21. 2011. [ http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=201.57 ]. [Last Accessed: 03/23/2012]
4. Boyce RD, Handler SM, Karp JF, Hanlon JT: Age-related changes in antidepressant pharmacokinetics and potential drug-drug interactions: a comparison of evidence-based literature and package insert information. Am J Geriatric Pharmacother 2012,10(2):139-150. [PMID: 22285509]
5. Steinmetz KL, Coley KC, Pollock BG: Assessment of geriatric information on the drug label for commonly prescribed drugs in older people. J Am Geriatrics Soc 2005,53(5):891-894. [ http://www.ncbi.nlm.nih.gov/pubmed/15877571 ]. [PMID: 15877571]
6. Hines L, Ceron-Cabrera D, Romero K, Anthony M, Woosley R, Armstrong E, Malone D: Evaluation of warfarin drug interaction listings in US product information for warfarin and interacting drugs. Clin Ther 2011, 33:36-45. [ http://www.ncbi.nlm.nih.gov/pubmed/21397772 ]. [PMID: 21397772]
7. Blake C: Beyond genes, proteins, and abstracts: Identifying scientific claims from full-text biomedical articles. J Biomed Informatics 2010,43(2):173-189.
8. Ciccarese P, Wu E, Wong GT, Ocana M, Kinoshita J, Ruttenberg A, Clark T: The SWAN biomedical discourse ontology. J Biomed Informatics 2008,41(5):739-751.
9. de Waard A, Buckingham Shum S, Carusi A, Park J, Samwald M, Sándor A: Hypotheses, evidence and relationships: The HypER approach for representing scientific knowledge claims. Proceedings of the Workshop on Semantic Web Applications in Scientific Discourse (SWASD 2009), co-located with the 8th International Semantic Web Conference (ISWC-2009) 2009.
10. Groza T, Möller K, Handschuh S, Trif D, Decker S: SALT: Weaving the claim web. In The Semantic Web: Research and Applications. Berlin /Heidelberg: Springer; 2007:197-210.
11. Groza T, Handschuh S, Möller K, Decker S: KonneX-SALT: first steps towards a semantic claim federation infrastructure. In The Semantic Web: Research and Applications, Volume 5021 of Lecture Notes in Computer Science. Edited by: Bechhofer S, Hauswirth M, Hoffmann J, Koubarakis M. Berlin /Heidelberg: Springer; 2008:80-94. [ http://dx.doi.org/10.1007/978-3-540-68234-9_9 ]
12. Marshall MS, Boyce R, Deus HF, Zhao J, Willighagen EL, Samwald M, Pichler E, Hajagos J, Prud'hommeaux E, Stephens S: Emerging practices for mapping and linking life sciences data using RDF - A case series. Web Semantics Science Services and Agents on the World Wide Web 2012,14(null):1-12. [ http://linkinghub.elsevier.com/retrieve/pii/S1570826812000376 ]
13. Heath T, Bizer C: Linked Data: evolving the web into a global data space. Synth Lectures on the Semantic Web: Theory and Technol 2011, 1:1-136. [ http://www.morganclaypool.com/doi/abs/10.2200/S00334ED1V01Y201102WBE001 ]
14. Boyce RD, Collins C, Clayton M, Kloke J, Horn JR: Inhibitory metabolic drug interactions with newer psychotropic drugs: inclusion in package inserts and influences of concurrence in drug interaction screening software. Ann Pharmacotherapy 2012,46(10):1287-98. [ http://www.theannals.com/content/early/2012/10/02/aph.1R150 ]
15. Hassanzadeh O, Kementsietsidis A, Lim L, Miller R, Wang M: LinkedCT: a linked data space for clinical trials. 2009. [ http://arxiv.org/abs/0908.0567 ]
16. Samwald M, Jentzsch A, Bouton C, Kallesøe C, Willighagen E, Hajagos J, Marshall M, Prud'hommeaux E, Hassanzadeh O, Pichler E, Stephens S: Linked open drug data for pharmaceutical research and development. J Cheminformatics 2011, 3:19. [ http://www.jcheminf.com/content/3/1/19/abstract ]
17. Brown SH, Elkin PL, Rosenbloom ST, Husser C, Bauer BA, Lincoln MJ, Carter J, Erlbaum M, Tuttle MS: VA National Drug File Reference Terminology: a cross-institutional content coverage study. Stud health technol informatics 2004,107(Pt 1):477-481. [PMID: 15360858]
18. Olvey E, Clauschee S, Malone D: Comparison of critical drug-drug interaction listings: the Department of Veterans Affairs medical system and standard reference compendia. Clin Pharmacol Ther 2010, 87:48-51. [ http://www.ncbi.nlm.nih.gov/pubmed/19890252 ]. [PMID: 19890252]
19. Boyce R, Collins C, Horn J, Kalet I: Computing with evidence Part II: An evidential approach to predicting metabolic drug-drug interactions. J Biomed Informatics 2009,42(6):990-1003. [ http://www.ncbi.nlm.nih.gov/pubmed/19539050 ]. [PMID: 19539050]
20. Liakata M, Saha S, Dobnik S, Batchelor C, D RS: Automatic recognition of conceptualisation zones in scientific articles and two life science applications. Bioinformatics 2012,28(7):991-1000.
21. Landis JR, Koch GG, The measurement of observer agreement for categorical data: Biometrics. 1977, 33:159-174. [ http://www.ncbi.nlm.nih.gov/pubmed/843571 ]. [PMID: 843571]
22. von Moltke L, Greenblatt D, Giancarlo G, Granda B, Harmatz J, Shader R: Escitalopram (S-citalopram) and its metabolites in vitro: cytochromes mediating biotransformation, inhibitory effects, and comparison to R-citalopram. Drug Metabol Dispos: Biol Fate Chem 2001,29(8):1102-1109. [ http://www.ncbi.nlm.nih.gov/pubmed/11454728 ]. [PMID: 11454728]
23. Forest Pharmaceuticals: Lexapro (escitalopram) tablets/oral solution. FDA-Approved Drug Product Labeling 2009.
24. FDA: FDA Guideline: Drug Interaction Studies - Study Design, Data Analysis, and Implications for Dosing and Labeling. Rockville, MD: Food and Drug Administration; 2006. [ http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm072101.pdf ]. [Last Accessed: 03/31/2010]
25. Sanofi-Aventis: RIFADIN (rifampin) capsule, RIFADIN IV (rifampin) injection, powder, lyophilized, for solution. FDA-Approved Drug Product Labeling 2010.
26. Hines LE, Murphy JE, Grizzle AJ, Malone DC: Critical issues associated with drug-drug interactions: Highlights of a multistakeholder conference. Am J Health-Syst Pharmacy 2011,68(10):941-946. [ http://www.ajhp.org/content/68/10/941.short ]
27. Boyce R, Collins C, Horn J, Kalet I: Computing with evidence Part I: A drug-mechanism evidence taxonomy oriented toward confidence assignment. J Biomed Inform 2009,42(6):979-989.
28. Hassanzadeh O, Xin R, Miller R, Kementsietsidis A, Lim L, Wang M: Linkage query writer. Proc VLDB Endowment 2009,2(2):1590-1593.
29. FDA: Advancing Regulatory Science at FDA. Rockville, MD: Food and Drug Administration; 2011. [ http://www.fda.gov/downloads/ScienceResearch/SpecialTopics/RegulatoryScience/UCM268225.pdf ]. [Last Accessed: 10/31/2012]
30. Medi-Physics Inc: DATSCAN (ioflupane i-123 and iodine) injection, solution. FDA-approved drug product labeling 2011.
31. Cohen AM, Hersh W: A survey of current work in biomedical text a survey of current work in biomedical text mining. Briefings in Bioinf 2005, 6:57-71.
32. Ananiadou S, Tsujii J, S P: Event extraction for systems biology by text mining the literature. Trends Biotechnol 2010,28(7):381-390.
33. Duke JFJ: A quantitative analysis of adverse events and "overwarning" in drug labeling. Arch Internal Med 2011,171(10):941-954. [ http://dx.doi.org/10.1001/archinternmed.2011.182 ]
34. Kuhn M, Campillos M, Letunic I, Jensen LJ, Bork P: A side effect resource to capture phenotypic effects of drugs. Mol Syst Biol 2010, 6:343. [PMID: 20087340]
35. Boyce R, Gardner G, Harkema H: Using natural language processing to extract drug-drug interaction information from package inserts. In BioNLP: Proceedings of the 2012 Workshop on Biomedical Natural Language Processing. Montréal, Canada: Association for Computational Linguistics; 2012:206-213. [ http://www.aclweb.org/anthology/W12-2426 ]
36. Takarabe M, Shigemizu D, Kotera M, Goto S, Kanehisa M: Network-based analysis and characterization of adverse drugâAŞdrug interactions. J Chem Inf Model 2011,51(11):2977-2985. [ http://dx.doi.org/10.1021/ci200367w ]
37. Rubrichi S, Quaglini S: Summary of Product Characteristics content extraction for a safe drugs usage. J Biomed Informatics 2012,45(2):231-239. [ http://www.ncbi.nlm.nih.gov/pubmed/22094356 ]. [PMID: 22094356]
38. Segura-Bedmar I, Martinez P, de Pablo-Sanchez C: Extracting drug-drug interactions from biomedical texts. BMC Bioinf 2010,11(Suppl 5):9.
39. Segura-Bedmar I, Martinez P, Sanchez-Cisneros D (Eds): Proceedings of the First Challenge Task: Drug-Drug Interaction Extraction 2011. Huelva, Spain; 2011. [ http://sunsite.informatik.rwth-aachen.de/Publications/CEUR-WS/Vol-761/ ]
40. Thomas P, Neves M, Solt I, Tikk D, Leser U: Relation extraction for drug-drug interactions using ensemble learning. In 1st Challenge task on Drug-Drug Interaction Extraction (DDIExtraction 2011). Huelva, Spain; 2011:11-18.
41. Coulet A, Shah NH, Garten Y, Musen M, Altman RB: Using text to build semantic networks for pharmacogenomics. J Biomed Informatics 2010,43(6):1009-1019. [PMID: 20723615]
42. Percha B, Garten Y, Altman RB: Discovery and explanation of drug-drug interactions via text mining. Pac Symp Biocomputing. Pac Symp Biocomputing 2012, 410-421. [ http://view.ncbi.nlm.nih.gov/pubmed/22174296 ]
43. Duke JD, Han X, Wang Z, Subhadarshini A, Karnik SD, Li X, Hall SD, Jin Y, Callaghan JT, Overhage MJ, Flockhart DA, Strother RM, Quinney SK, Li L: Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions. PLoS Comput Biol 2012,8(8):e1002614. [ http://www.ncbi.nlm.nih.gov/pubmed/22912565 ]. [PMID: 22912565]
44. Tari L, Anwar S, Liang S, Cai J, Baral C: Discovering drug-drug interactions: a text-mining and reasoning approach based on properties of drug metabolism. Bioinformatics (Oxford, England) 2010,26(18):i547-553. [PMID: 20823320]
45. FDA: Providing Regulatory Submissions in Electronic Format - Content of Labeling. Guidance for Industry UCM072331, Food and Drug Administration, Rockville, MD 2005. [ http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM072331.pdf ] Guidance for Industry UCM072331, Food and Drug Administration, Rockville, MD 2005.
46. Regenstrief Institute Inc: Logical Observation Identifiers Names and Codes (LOINC ) - LOINC. 2012. [ http://loinc.org/ ]
47. National Library of Medicine: DailyMed. 2012. [ http://dailymed.nlm.nih.gov/dailymed/about.cfm ]
48. Cyganiak R: The D2RQ platform - accessing relational databases as virtual RDF graphs. 2012. [ http://d2rq.org/ ].
49. Semla TP, Beizer JL, Higbee MD (Eds): Geriatric Dosage Handbook 2012: Including Clinical Recommendations and Monitoring Guidelines. Lexi Comp. 2011.
50. Sutton C, McCallum A: An Introduction to Conditional Random Fields. Rapport Technique MSCIS0421 Department of Computer and Information Science University of Pennsylvania 2010,50(7):9. [ http://arxiv.org/abs/1011.4088 ]